These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results. Mane I, Cartel JL, Grosset JH. Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595 [Abstract] [Full Text] [Related]
8. Clinical, bacteriological and histopathological study of 62 referral relapse cases between Jan 2004 and Dec 2009 at the Foundation for Medical Research, Mumbai. Shetty VP, Wakade AV, Ghate SD, Pai VV. Lepr Rev; 2011 Sep; 82(3):235-43. PubMed ID: 22125931 [Abstract] [Full Text] [Related]
9. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin. Katoch K, Katoch VM, Natarajan M, Gupta UD, Sharma VD, Singh HB. Indian J Lepr; 2008 Sep; 80(4):331-44. PubMed ID: 20329382 [Abstract] [Full Text] [Related]
10. A comparative trial of single dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions. 2-3 Lesion Multicentre Trial Group. Indian J Lepr; 2001 Sep; 73(2):131-43. PubMed ID: 11579649 [Abstract] [Full Text] [Related]
14. A study on trend of relapse in leprosy and factors influencing relapse. Ali MK, Thorat DM, Subramanian M, Parthasarathy G, Selvaraj U, Prabhakar V. Indian J Lepr; 2005 Sep; 77(2):105-15. PubMed ID: 16044808 [Abstract] [Full Text] [Related]
15. Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy. Single-lesion Multicentre Trial Group. Indian J Lepr; 1997 Sep; 69(2):121-9. PubMed ID: 9290963 [Abstract] [Full Text] [Related]
16. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions. Deshmukh AR, Dhurat RS, Jerajani HR. Indian J Lepr; 2003 Sep; 75(3):209-17. PubMed ID: 15267190 [Abstract] [Full Text] [Related]
17. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients. Penna GO, Bührer-Sékula S, Kerr LRS, Stefani MMA, Rodrigues LC, de Araújo MG, Ramos AMC, de Andrade ARC, Costa MB, Rosa PS, Gonçalves HS, Cruz R, Barreto ML, Pontes MAA, Penna MLF. PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363 [Abstract] [Full Text] [Related]
18. Ofloxacin-Containing Multidrug Therapy in Ambulatory Leprosy Patients: A Case Series. Faust L, Klowak M, MacRae C, Kopalakrishnan S, Showler AJ, Boggild AK. J Cutan Med Surg; 2021 Jul; 25(1):45-52. PubMed ID: 32869655 [Abstract] [Full Text] [Related]
19. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B. Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [Abstract] [Full Text] [Related]
20. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil. Cunha Mda G, Virmond M, Schettini AP, Cruz RC, Ura S, Ghuidella C, Viana Fdos R, Avelleira JC, Campos AA, Filho B. Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027 [Abstract] [Full Text] [Related] Page: [Next] [New Search]